Ignite Creation Date:
2024-05-05 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00141232
Status:
COMPLETED
Last Update Posted:
2021-02-18
First Post:
2005-08-30
Brief Title:
Evaluating Atorvastatin With Omega-3 Fatty Acids in Cardiovascular Risk Reduction in Patients With Type 2 Diabetes
Sponsor:
Pfizers Upjohn has merged with Mylan to form Viatris Inc
Organization:
Pfizer
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Diabetes Type 2 |
Keywords: